What is right and what is wrong about evidence-based medicine?

Journal of Cardiovascular Electrophysiology

Volumn 14, Issue 9 SUPPL., 2003, Pages

  Julian, Desmond G ^a,b  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b NONE   (United Kingdom)

Author keywords

Bias; Evidence based medicine; Extrapolation; Randomized trials

Indexed keywords

ANTITHROMBOCYTIC AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; FIBRINOLYTIC AGENT; METOPROLOL;

ACUTE HEART INFARCTION; BLOOD PRESSURE; CLINICAL MEDICINE; CLINICAL PRACTICE; CLINICAL RESEARCH; CLINICAL TRIAL; CONFERENCE PAPER; DATA ANALYSIS; DEFIBRILLATION; EVIDENCE BASED MEDICINE; FOLLOW UP; HEART INFARCTION; HEART REHABILITATION; HUMAN; INFORMATION PROCESSING; META ANALYSIS; MORTALITY; PATIENT; PRIORITY JOURNAL; PUBLISHING; RESUSCITATION; RISK FACTOR; SCIENTIFIC LITERATURE;

EID: 0141501389     PISSN: 10453873     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1540-8167.14.s9.18.x     Document Type: Conference Paper

References (21)

1. Yusuf S, Cairns JA, Camm AJ, Fallen EL, Gersh BJ, eds: Evidence-Based Cardiology. London: BMJ, 1998.
2. Sharis PJ, Cannon CP: Evidence-Based Cardiology. Philadelphia: Lippincott Williams & Wilkins, 1999.
3. Mehta S, Urban P, De Benedetti E: Acute myocardial infarction. In Barton S, ed: Clinical Evidence. London: BMJ, 2001.
4. Yusuf S, Cairns JA, Camm AJ, Fallen EL, Gersh BJ: Evidence-Based Cardiology. London: BMJ, 2003.
5. Thompson PL, McKeown B: Complications after myocardial infarction. In:Yusuf S, Cairns JA, Camm AJ, Fallen EL, Gersh BJ, eds. Evidence-Based Cardiology. London: BMJ, 2003, p. 496.
6. Norris RM: Sudden Cardiac Death and Acute Myocardial Infarction in Three British Health Districts: The UK Heart Attack Study. London: British Heart Foundation, 1999.
7. Julian DG, Norris RM: Myocardial infarction: Is evidence based medicine the best? Lancet 2002;359:1515-1516.
8. ISIS-1 (First International Study of Infarct Survival) Collaborative Group: Randomised trial of intravenous atenolol among 16027 cases of suspected myocardial infarction: ISIS-1. Lancet 1986;ii:57-66.
9. Maggioni AP, Latini R, Tognoni G, Sleight P: Pain relief, general management, and other adjunctive treatments. InYusuf S, Cairns JA, Camm AJ, Fallen EL, Gersh BJ, eds: Evidence-Based Cardiology. London: BMJ, 2003.
10. Freemantle N, Cleland J, Young P, Mason J, Harrison J: Beta blockade after myocardial infarction: Systematic review and meta regression analysis. BMJ 1999;318:1730-1737.
11. ISIS-1 (First International Study of Infarct Survival) Collaborative Group: Mechanisms for the early mortality reduction produced by beta-blockade started early in acute myocardial infarction: ISIS-1. Lancet 1988;i:921-923.
12. Olsson G, Lubsen J, Van Es GA, Rehnqvist N: Quality of life after myocardial infarction: effect of long term metoprolol on mortality and morbidity. BMJ 1986;292:1491-1493.
13. Aronow WS: Approach to symptomatic coronary disease in the elderly: TIME to change? Lancet 2001;358:945-946.
14. GREAT Group: Feasibility, safety, and efficacy of domiciliary thrombolysis by general practitioners. BMJ 1992;305:548-553.
15. Oldridge NB, Guyatt GH, Fischer MD, Rimm AA: Cardiac rehabilitation after myocardial infarction: Combined experience of randomized clinical trials. JAMA 1988;260:945-950.
16. O'Connor GT, Buring JE, Yusuf S, Goldhaber SZ, Olmstead EM, Paffenbarger RS Jr, Hennekens CH: Overview of randomized trials of rehabilitation after myocardial infarction. Circulation 1989;80:234-244.
17. Jolliffe JA, Rees K, Taylor RS, Thompson D, Oldridge N, Ebrahim S: Exercise-based rehabilitation for coronary heart disease (Cochrane Review). In: The Cochrane Library, Issue 1. Oxford: Update Software, 2003.
18. The TIME Investigators: Trial of invasive versus medical therapy in elderly patients with chronic symptomatic coronary-artery disease (TIME): A randomised trial. Lancet 2001;358:951-977.
19. Pfisterer M, Buser P, Osswald S, Alleman U, Amann W, Anghrn W, et al: Outcome of elderly patients with chronic symptomatic coronary artery disease with an invasive vs optimized medical treatment strategy: 1 year results of the randomized TIME trial. JAMA 2003;289:1117-1123.
20. Rosser RR: Aspirin for the primary prevention of cardiovascular events. Lancet 2001;357:84-85.
21. Collaborative Group of the Primary Prevention Project (PPP): Low-dose aspirin and vitamin E in people at cardiovascular risk: A randomised trial in general practice. Lancet 2001;357:89-95.